The Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena (Germany), is a federal and state government-funded research institute and member of the Leibniz Association (Wissenschaftsgemeinschaft Gottfried Wilhelm Leibniz e.V.). FLI’s internationally visible and highly competitive research is focused on understanding the mechanisms of aging and associated age-related diseases. Scientists from over 40 countries are currently investigating the molecular mechanisms of aging and the occurrence of age-related diseases. Our aim is to create the basis for new approaches in medicine as a way to improve health in the elderly (www.leibniz-fli.de).
The “Transcriptional Control of Tissue Homeostasis” group, headed by Dr. Björn von Eyss invites applications for a
Tasks and Challenges:
The von Eyss Lab studies the Hippo pathway and its impact on organ regeneration, cancer and aging.
To this end, state-of-the-art NGS-based and single-cell technologies (e.g. scRNA-Seq, scATAC-Seq, CROP-Seq, ChIP-Seq, RNA-Seq, 4 C-Seq, genome-wide CRISPR screens), inducible mouse models, as well as biochemical methods are applied.
This specific project will focus on the two transcriptional Hippo pathway co-activators YAP and TAZ in cancer, tissue homeostasis and regeneration. Here we will apply novel mouse models that allow a reversible modulation of the YAP/TAZ function in the mouse.
Candidates are encouraged to send their application (Job-ID 20/16) latest by November 30th, 2020.
Leibniz-Institut für Alternsforschung—Fritz-Lipmann-Institut e.V.
Beutenbergstraße 11 | 07745 JenaContinue reading
|Employer||Leibniz Institute on Aging – Fritz Lipmann Institute e. V. (FLI)|
|Job location||Beutenbergstraße 11, D-07745 Jena|
|Published||October 29, 2020|
|Application deadline||November 30, 2020|
|Job types||Postdoc  |
|Fields||Biomedicine,   Cancer Research,   Gerontology,   Biochemistry,   Bioinformatics,   Molecular Biology,   Cell Biology  |